Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 3 Clinico-pathological characteristics of HNSCC patients enrolled in the study of T cell profile

From: Regulatory and effector T cell subsets in tumor-draining lymph nodes of patients with squamous cell carcinoma of head and neck

Characteristics

Value

Age (years)

61.2 ± 15.8 (27–88)

Gender

 

 Male

28 (71.8%)

 Female

11 (28.2%)

Tumor Type

 

 Larynx

17 (43.6%)

 Tongue (from oral cavity)

22 (56.4%)

Lymph node (LN) Status(greatest dimension, cm)

 

 N0 (free LNs)

24 (61.5%)

 N1 (≤ 3)

4 (10.3%)

 N2 (> 3–6)

9 (23.1%)

 N3 (> 6)

1 (2.6%)

 Unknown

1 (2.6%)

Tumor size

 

 T1

4 (10.3%)

 T2

12 (30.8%)

 T3

15 (38.5%)

 T4

7 (17.9%)

 Unknown

1(2.6%)

Stage

 

 I

4 (10.3%)

 II

9 (23.1%)

 III

10 (25.6%)

 IV

15 (38.5%)

 Unknown

1 (2.6%)

Histological grade*

 

 Well differentiated (I)

19 (48.7%)

 Moderately differentiated (II)

15 (38.5%)

 Poorly differentiated (III)

3 (7.7%)

 Unknown

2 (5.1%)

Perineural/lymphovascular invasion

 

 Positive

8 (20.5%)

 Negative

30 (76.9%)

 Unknown

1 (2.6%)

Lymph nodes characteristic

 

 MLNs

11 (28.2%)

 nMLNs

24 (61.5%)

 Not determined

4 (10.3%)

  1. Based on Bryne’s (1989, 1992) (ITF) Invasive Tumor Front Grading System
  2. MLN, metastatic lymph node; nMLN, non-metastatic lymph node